BACKGROUND: Chemotherapy-induced alopecia (CIA) has a devastating cosmetic effect, especially in the young. Recent data indicate that two major basement membrane components (laminin-332 and -511) of the skin have opposing effects on hair growth. OBJECTIVE: In this study, we examined the role and localization of laminin-332 and -511 in CIA. METHODS: We examined the expression of laminin-332 and -511 during the dystrophic catagen form of CIA induced in C57BL/6 mice by cyclophosphamide (CYP) treatment. RESULTS: Our data indicate that both laminin-332 and its receptor alpha 6 beta 4 integrin are up-regulated (both quantitatively and spatially) after mid to late dystrophic catagen around the outer root sheath (ORS) in the lower third of hair follicles in CIA. This up-regulation also occurs at the transcriptional level. In contrast, laminin-511 is down-regulated after mid dystrophic catagen at the protein level, with transcriptional inactivation of laminin-511 occurring transiently at the early dystrophic catagen stage in both epidermal and ORS keratinocytes. Laminin-511 expression correlates with expression of alpha 3 integrin in CIA and we also demonstrate that laminin-511 can up-regulate the activity of the alpha 3 integrin promoter in cultured keratinocytes. Injection of a laminin-511 rich protein extract, but not recombinant laminin-332, in the back skin of mice delays hair loss in CYP-induced CIA. CONCLUSIONS: We propose that abrupt hair loss in CIA is, at least in part, caused by down-regulation of laminin-511 and up-regulation of laminin-332 at the transcriptional and translational levels. (c) 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
BACKGROUND: Chemotherapy-induced alopecia (CIA) has a devastating cosmetic effect, especially in the young. Recent data indicate that two major basement membrane components (laminin-332 and -511) of the skin have opposing effects on hair growth. OBJECTIVE: In this study, we examined the role and localization of laminin-332 and -511 in CIA. METHODS: We examined the expression of laminin-332 and -511 during the dystrophic catagen form of CIA induced in C57BL/6 mice by cyclophosphamide (CYP) treatment. RESULTS: Our data indicate that both laminin-332 and its receptor alpha 6 beta 4 integrin are up-regulated (both quantitatively and spatially) after mid to late dystrophic catagen around the outer root sheath (ORS) in the lower third of hair follicles in CIA. This up-regulation also occurs at the transcriptional level. In contrast, laminin-511 is down-regulated after mid dystrophic catagen at the protein level, with transcriptional inactivation of laminin-511 occurring transiently at the early dystrophic catagen stage in both epidermal and ORS keratinocytes. Laminin-511 expression correlates with expression of alpha 3 integrin in CIA and we also demonstrate that laminin-511 can up-regulate the activity of the alpha 3 integrin promoter in cultured keratinocytes. Injection of a laminin-511 rich protein extract, but not recombinant laminin-332, in the back skin of micedelays hair loss in CYP-induced CIA. CONCLUSIONS: We propose that abrupt hair loss in CIA is, at least in part, caused by down-regulation of laminin-511 and up-regulation of laminin-332 at the transcriptional and translational levels. (c) 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
Authors: Jie Li; Julia Tzu; Yi Chen; Yan-Ping Zhang; Ngon T Nguyen; Jing Gao; Maria Bradley; Douglas R Keene; Anthony E Oro; Jeffrey H Miner; M Peter Marinkovich Journal: EMBO J Date: 2003-05-15 Impact factor: 11.598
Authors: Andrei A Sharov; Frank Siebenhaar; Tatyana Y Sharova; Natalia V Botchkareva; Barbara A Gilchrest; Vladimir A Botchkarev Journal: Cancer Res Date: 2004-09-01 Impact factor: 12.701
Authors: S T Davis; B G Benson; H N Bramson; D E Chapman; S H Dickerson; K M Dold; D J Eberwein; M Edelstein; S V Frye; R T Gampe; R J Griffin; P A Harris; A M Hassell; W D Holmes; R N Hunter; V B Knick; K Lackey; B Lovejoy; M J Luzzio; D Murray; P Parker; W J Rocque; L Shewchuk; J M Veal; D H Walker; L F Kuyper Journal: Science Date: 2001-01-05 Impact factor: 47.728
Authors: V A Botchkarev; E A Komarova; F Siebenhaar; N V Botchkareva; P G Komarov; M Maurer; B A Gilchrest; A V Gudkov Journal: Cancer Res Date: 2000-09-15 Impact factor: 12.701
Authors: S Müller-Röver; H Rossiter; R Paus; B Handjiski; E M Peters; J E Murphy; L Mecklenburg; T S Kupper Journal: Am J Pathol Date: 2000-04 Impact factor: 4.307